Loading clinical trials...
Loading clinical trials...
A Phase II Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study Investigating the Safety and Efficacy of Omnitram in Diabetic Neuropathy
Conditions
Interventions
Omnitram Oral Tablet
Placebo Oral Tablet
Locations
4
United States
Orange County Research Institute
Anaheim, California, United States
Core Healthcare Group
Cerritos, California, United States
St. Louis Clinical Trials
St Louis, Missouri, United States
Endeavor Clinical Trials, LLC
San Antonio, Texas, United States
Start Date
November 15, 2018
Primary Completion Date
August 17, 2020
Completion Date
August 17, 2020
Last Updated
September 30, 2021
NCT07436806
NCT06726954
NCT07057128
NCT07285018
NCT07293780
NCT07403331
Lead Sponsor
Syntrix Biosystems, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions